Hyperfine Stock News

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the BTIG Digital Health Forum on November 25, 2024 and the Mizuho Healthcare Conference on December 11, 2024.

Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon.

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation.

MADRID--(BUSINESS WIRE)--Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer's disease.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces that it will report financial results for the third quarter 2024 on Tuesday, November 12, 2024.

GUILFORD, Conn.--(BUSINESS WIRE)--Investigators at Johns Hopkins Hospital and the University of Texas-Houston publish study using the Swoop® system for patients on ECMO support.

PARIS--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of interim data supporting the role portable ultra-low-field MRI can play in acute stroke workup in a hospital emergency department...